Wealth in Singapore Market Analysis and Growth Forecast by Regions, Type and Application to 2023

Singapore is Asia’s pre-eminent offshore investment center, with 80% of the wealth invested in funds sourced from non-residents in 2015. However, the onshore market is a major source of assets under management (AUM) in its own right, with 1.2 million affluent individuals in 2016 despite the city state’s small population. An onshore operation is clearly worth the effort for any wealth manager targeting mass affluent investors.

Specifically the report -
* Sizes the affluent market (both by number of individuals and the value of their liquid assets) using our proprietary datasets.
* Analyzes which asset classes are favored by Singaporean investors and how their preferences impact the growth of the total savings and investments market.
* Examines HNW clients’ attitudes towards non-traditional investments, such as property and commodities.
* Identifies key drivers and booking centers for offshore investments.
* Examines the tax landscape in Singapore and future implications for investors.

Browse Detail Report With TOC @
http://www.hexareports.com/report/wealth-in-singapore-sizing-the-market-opportunity-2017

Scope
* HNW individuals totaled 29,660 in 2016 – little changed from 2015, a tiny proportion of the overall population, and well below the levels seen in other wealth hubs such as the US and Switzerland.
* HNW liquid assets growth will slow to 7.0% a year between 2015 and 2020.
* Bonds will be the fastest-growing asset class, but more due to greater availability than client demand.
* While Singapore attracts significant offshore investment, HNW residents are also keen to invest abroad, with almost half of AUM invested offshore.

Request A Sample copy of This Report @
http://www.hexareports.com/report/wealth-in-singapore-sizing-the-market-opportunity-2017/request-sample

Reasons To Buy
1. Benchmark your share of the Singaporean wealth market against the current market size.
2. Forecast your future growth prospects using our projections for the market to 2020.
3. Identify your most promising client segment by analyzing penetration of affluent individuals in Singapore.
4. Evaluate your HNW proposition by understanding how the Singaporean tax system impacts HNW clients.
5. Review your offshore strategy by identifying HNW motivations for offshore investments and their preferred booking centers.

Browse More Financial Services Related Market Research Reports:

• Banking as a Marketplace: Opportunities and Threats -
http://www.hexareports.com/report/banking-as-a-marketplace-opportunities-and-threats

• Consumer Payments Country Snapshot: Canada 2016 -
http://www.hexareports.com/report/consumer-payments-country-snapshot-canada-2016

• Advisory Asset Management: HNW Demand and Drivers -
http://www.hexareports.com/report/advisory-asset-management-hnw-demand-and-drivers

Aesthetic Lasers and Energy Devices Market Study by Price, Revenue and Gross Margin Analysis with its important Types and Application to 2023

The report provides value, in millions of US dollars, volume (in units) and and average prices (USD) within market segments – Minimally Invasive Body Contouring Devices, Non Invasive Body Contouring Devices and Laser Resurfacing Devices.

The report also provides company shares and distribution shares data for each of these market segments, and global corporate-level profiles of the key market participants. Based on the availability of data for the particular market and country, information related to pipeline products, news and deals is available in the report.

Browse Detail Report With TOC @
http://www.hexareports.com/report/italy-aesthetic-lasers-and-energy-devices-market-outlook-to-2023

Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the market size, company share and distribution share data and analysis.

Scope
* Market size and company share data for Aesthetic Lasers and Energy Devices market segments – Minimally Invasive Body Contouring Devices, Non Invasive Body Contouring Devices and Laser Resurfacing Devices.
* Annualized market revenues (USD million) and volume (units) data for each of the market segments. Data is provided from 2009 to 2016 and forecast to 2023.
* 2016 company shares and distribution shares data for each of the market segments.
* Global corporate-level profiles of key companies operating within the Italy Aesthetic Lasers and Energy Devices market.
* Key players covered include Cynosure, Inc., Syneron Medical Ltd, Valeant Pharmaceuticals International Inc and Others.

Request A Sample copy of This Report @
http://www.hexareports.com/report/italy-aesthetic-lasers-and-energy-devices-market-outlook-to-2023/request-sample

Reasons To Buy
1. Develop business strategies by identifying the key market segments poised for strong growth in the future.
2. Develop market-entry and market expansion strategies.
3. Design competition strategies by identifying who-stands-where in the market.
4. Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.
5. What are the key distribution channels and what’s the most preferred mode of product distribution – Identify, understand and capitalize.

Browse More Medical Devices Related Market Research Reports:

• Russia Aesthetic Lasers and Energy Devices Market Outlook to 2023 -
http://www.hexareports.com/report/russia-aesthetic-lasers-and-energy-devices-market-outlook-to-2023

• Russia Surgical Generators Market Outlook to 2023 -
http://www.hexareports.com/report/russia-surgical-generators-market-outlook-to-2023

• Russia Ureteroscopes Market Outlook to 2023 -
http://www.hexareports.com/report/russia-ureteroscopes-market-outlook-to-2023

Ureteroscopes Market Growth Forecast, Demand and Development Research Report to 2023

The report provides value, in millions of US dollars, volume (in units) and and average prices (USD) within market segments – Non-Video Ureteroscopes and Flexible Video Ureteroscopes.

The report also provides company shares and distribution shares data for each of these market segments, and global corporate-level profiles of the key market participants. Based on the availability of data for the particular market and country, information related to pipeline products, news and deals is available in the report.

Browse Detail Report With TOC @
http://www.hexareports.com/report/germany-ureteroscopes-market-outlook-to-2023

Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the market size, company share and distribution share data and analysis.

Scope
* Market size and company share data for Ureteroscopes market segments – Non-Video Ureteroscopes and Flexible Video Ureteroscopes.
* Annualized market revenues (USD million) and volume (units) data for each of the market segments. Data is provided from 2009 to 2016 and forecast to 2023.
* 2016 company shares and distribution shares data for each of the market segments.
* Global corporate-level profiles of key companies operating within the Germany Ureteroscopes market.
* Key players covered include Olympus Corporation, KARL STORZ GmbH & Co KG and Others.

Request A Sample copy of This Report @
http://www.hexareports.com/report/germany-ureteroscopes-market-outlook-to-2023/request-sample

Reasons To Buy
1. Develop business strategies by identifying the key market segments poised for strong growth in the future.
2. Develop market-entry and market expansion strategies.
3. Design competition strategies by identifying who-stands-where in the market.
4. Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.
5. What are the key distribution channels and what’s the most preferred mode of product distribution – Identify, understand and capitalize.

Browse More Medical Devices Related Market Research Reports:

• Italy Ureteroscopes Market Outlook to 2023 -
http://www.hexareports.com/report/italy-ureteroscopes-market-outlook-to-2023

• Spain Aesthetic Lasers and Energy Devices Market Outlook to 2023 -
http://www.hexareports.com/report/spain-aesthetic-lasers-and-energy-devices-market-outlook-to-2023

• Spain Surgical Generators Market Outlook to 2023 -
http://www.hexareports.com/report/spain-surgical-generators-market-outlook-to-2023

Surgical Generators Market Report Research Analysis, Growth Opportunities and Recent Trends by Leading Regions, Types and Application from 2017 to 2023

The report provides value, in millions of US dollars, volume (in units) and and average prices (USD) within market segments – Argon Plasma Coagulation Generators, Electrosurgical RF Generators, Electrocautery Generators and Ultrasonic Generators.

The report also provides company shares and distribution shares data for each of these market segments, and global corporate-level profiles of the key market participants. Based on the availability of data for the particular market and country, information related to pipeline products, news and deals is available in the report.

Browse Detail Report With TOC @

http://www.hexareports.com/report/germany-surgical-generators-market-outlook-to-2023

Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the market size, company share and distribution share data and analysis.

Scope
* Market size and company share data for Surgical Generators market segments – Argon Plasma Coagulation Generators, Electrosurgical RF Generators, Electrocautery Generators and Ultrasonic Generators.
* Annualized market revenues (USD million) and volume (units) data for each of the market segments. Data is provided from 2009 to 2016 and forecast to 2023.
* 2016 company shares and distribution shares data for each of the market segments.
* Global corporate-level profiles of key companies operating within the Germany Surgical Generators market.
* Key players covered include Olympus Corporation, Medtronic plc, ERBE Elektromedizin GmbH and Others.

Request A Sample copy of This Report @
http://www.hexareports.com/report/germany-surgical-generators-market-outlook-to-2023/request-sample

Reasons To Buy
1. Develop business strategies by identifying the key market segments poised for strong growth in the future.
2. Develop market-entry and market expansion strategies.
3. Design competition strategies by identifying who-stands-where in the market.
4. Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.
5. What are the key distribution channels and what’s the most preferred mode of product distribution – Identify, understand and capitalize.

Browse More Medical Devices Related Market Research Reports:

• Germany Ureteroscopes Market Outlook to 2023 -
http://www.hexareports.com/report/germany-ureteroscopes-market-outlook-to-2023

• Italy Aesthetic Lasers and Energy Devices Market Outlook to 2023 -
http://www.hexareports.com/report/italy-aesthetic-lasers-and-energy-devices-market-outlook-to-2023

• Italy Surgical Generators Market Outlook to 2023 -
http://www.hexareports.com/report/italy-surgical-generators-market-outlook-to-2023

Osteoporosis Therapeutics Market Research Size, Share, Trends Analysis and Growth Forecast by Regions, Type and Application to 2022

Osteoporosis, the most common metabolic bone disease, is characterized by low bone mass, microarchitectural deterioration of bone tissue, and a consequent increase in fracture risk. Osteoporosis is generally known as an asymptomatic disease, as there are no visible signs until a fracture occur. In most of the cases, fracture is the clinical outcome associated with osteoporosis, and it has a complex pathogenesis that involves trauma to the bone and increased skeletal fragility.

Osteoporosis is a major global public health problem, associated with significant morbidity, mortality, and socioeconomic burden. An aging global population will result in an increased number of people living with the condition, thereby acting as a driver for revenue growth.

The osteoporosis market is undergoing a gradual transition from a focus on antiresorptive therapies to anabolic drug treatment. The market is set to be driven by recently launched products, and the approval of drugs that will supplement current market leaders and offer greater therapeutic options.

Browse Detail Report With TOC @
http://www.hexareports.com/report/osteoporosis-therapeutics-in-asia-pacific-markets-to-2022

The marketed products landscape comprises a wide range of treatment options, including bisphosphonates, SERMs, RANKL inhibitors, a dual-action non-bisphosphonate (strontium ranelate), calcitonins and PTH analogues. Nevertheless, significant unmet need remains for products that can improve bone formation, as well as effective antiresorptive therapies that offer increased compliance with few side effects.

Scope
* The osteoporosis Asia-Pacific market will be valued at $7.7 billion in 2022, growing from $4.5 billion in 2015 at a CAGR of 7.8%.
o Bisphosphonates and SERMs dominate the osteoporosis market. However, unmet needs exist in terms of safety and efficacy. Will the drugs under development fulfill the unmet needs of the osteoporosis market?
o How will immunotherapies such as Prolia contribute to growth?
o What effect will the patent expirations of currently branded therapies have on market value?
* The pipeline contains a range of molecule types and molecular targets, including those that are well established in osteoporosis, and novel, first-in-class therapies.
o Which molecular targets appear most frequently in the pipeline?
o Is there strong potential for the pipeline to address unmet needs within the osteoporosis market?
o Will the pipeline address unmet needs related to limited anabolic therapies for osteoporosis patients?

Request A Sample copy of This Report @
http://www.hexareports.com/report/osteoporosis-therapeutics-in-asia-pacific-markets-to-2022/request-sample

Reasons to buy
1. Understand the current clinical and commercial landscape by considering disease pathogenesis, diagnosis, prognosis, and the treatment options available at each stage of diagnosis, including a clinical comparison of marketed therapies.
2. Visualize the composition of the osteoporosis market in terms of dominant therapies, with their clinical and commercial standing. Unmet needs are highlighted to allow a competitive understanding of gaps in the current market.
3. Analyze the osteoporosis pipeline and stratify pipeline therapies by stage of development, molecule type and molecular target.
4. Understand the potential of late-stage therapies, with extensive profiles of products that could enter the market over the forecast period, highlighting clinical performance, potential commercial positioning, – and how they will compete with other therapies.
5. Predict osteoporosis market growth in the five Asia-Pacific markets with epidemiological and annual cost of therapy forecasts across India, China, Australia, South Korea and Japan, as well as individual contributions of promising late-stage molecules to market growth.
6. Identify commercial opportunities in the osteoporosis deals landscape by analyzing trends in licensing and co-development deals.

Browse More Pharmaceuticals & Healthcare Related Market Research Reports:

• Antibacterial Therapies Drug Development Pipeline Review, 2017 -
http://www.hexareports.com/report/antibacterial-therapies-drug-development-pipeline-review-2017

• Cardiovascular Disorders Drug Development Pipeline Review, 2017 -
http://www.hexareports.com/report/cardiovascular-disorders-drug-development-pipeline-review-2017

• Colorectal Cancer – Heat Map and Analysis -
http://www.hexareports.com/report/colorectal-cancer-heat-map-and-analysis

Non-Small Cell Lung Cancer Therapeutics Market Growth Analysis, Trends Forecast by Regions, Type and Application to 2022

Non-Small Cell Lung Cancer (NSCLC) is the most common cancer and cause of cancer-related mortality globally. There were more than 1.8 million newly diagnosed lung cancer cases in 2012 globally, accounting for 13% of the total number of cancer cases. Over half of the incident cases of NSCLC are diagnosed in patients over the age of 65 – a high-risk age range for lung cancer. As the aged population is projected to increase, the prevalence of lung cancer is anticipated to increase, thereby acting as a driver for revenue growth. The poor prognosis, particularly for patients with advanced disease, has created a pressing need for improved therapeutic options. The NSCLC market is undergoing a gradual change from a focus on generic chemotherapy regimens to a complex treatment landscape based on different NSCLC subtypes.

In the current market, patients with non-squamous histology can be treated with more efficacious therapies such as Alimta (pemetrexed), while patients harboring activating mutations in EGFR or ALK can be prescribed targeted therapies such as Tarceva, Iressa, Xalkori and Gilotrif. Opdivo (nivolumab) – a mAb immune checkpoint inhibitor targeted towards Programmed cell Death (PD) 1 – is a recent market entrant, gaining approval for treating advanced.

Browse Detail Report With TOC @
http://www.hexareports.com/report/non-small-cell-lung-cancer-therapeutics-in-asia-pacific-markets-to-2022

While the NSCLC developmental pipeline must aim to improve the outlook for all patients, there is currently a lack of options for patients with squamous cell histology or other detectable molecular characteristics besides EFGR and ALK mutations. Therapies that target mutant T790M and KRAS are being developed in the pipeline, with osimertinib, targeting T790M, gaining approval in Japan in 2016.

Scope
* The NSCLC Asia-Pacific market will be valued at $4.9 billion in 2022, growing from $2.7 billion in 2015 at a CAGR of 8.7%.
o How will immunotherapies such as Keytruda contribute to the growth?
o What effect will patent expirations of currently branded therapies have on market value?
* The NSCLC pipeline is large and diverse, with an increased presence of mAbs and targeted therapies.
o What are the common targets and mechanisms of action of pipeline therapies?
o Will the pipeline address unmet needs such as a lack of treatments for squamous cell patients?
o What implications will the increased focus on targeted therapies have on the future of NSCLC treatment?
* Numerous late-stage pipeline therapies with a strong clinical record have the potential to enter the market over the forecast period.
o How have the late-stage therapies performed in clinical trials?
o How would the approval of rociletinib to treat T790M mutant patients affect the competitive
* landscape, with its competitor osimertinib (AZD-9291) already approved in Japan in 2016?
o How would the approval of abemaciclib to treat KRAS mutant patients affect the competitive
o landscape, with no targeted therapy currently available to address this patient subset?

Request A Sample copy of This Report @
http://www.hexareports.com/report/non-small-cell-lung-cancer-therapeutics-in-asia-pacific-markets-to-2022/request-sample

Reasons to buy
1. Understand the current clinical and commercial landscape by considering disease pathogenesis, diagnosis, prognosis, and the treatment options available at each stage of diagnosis, including a clinical comparison of marketed therapies.
2. Visualize the composition of the NSCLC market in terms of dominant therapies for each patient subset along with their clinical and commercial standing. Unmet needs are highlighted to allow a competitive understanding of gaps in the current market.
3. Analyze the NSCLC pipeline and stratify pipeline therapies by stage of development, molecule type and molecular target.
4. Understand the potential of late-stage therapies with extensive profiles of products that could enter the market over the forecast, highlighting clinical performance, potential commercial positioning, and how they will compete with other therapies.
5. Predict NSCLC market growth in the five Asia-Pacific markets with epidemiological and annual cost of therapy forecasts across India, China, Australia, South Korea and Japan, as well as individual contributions of promising late-stage molecules to market growth.

Browse More Pharmaceuticals & Healthcare Related Market Research Reports:

• Type 1 Diabetes Mellitus – Heat Map and Analysis -
http://www.hexareports.com/report/type-1-diabetes-mellitus-heat-map-and-analysis

• Prostate Cancer – Heat Map and Analysis -
http://www.hexareports.com/report/prostate-cancer-heat-map-and-analysis

• Type 2 Diabetes Mellitus – Heat Map and Analysis -
http://www.hexareports.com/report/type-2-diabetes-mellitus-heat-map-and-analysis

Urological Cancer Market Segmentation and Analysis by Recent Trends, Development and Growth by Regions to 2022

Urological cancers are thought to account for 19.5% of global cancer prevalence, with kidney, prostate, testicular and bladder cancer – the key indications covered in this report – accounting for the majority of that figure. Urological cancers affect the male and female urinary tract and the male reproductive organs. Prostate cancer is the most prevalent of these malignancies.

A number of common etiologic factors have been strongly characterized as raising the risk of developing urological cancers, including age, chronic inflammation, gender, obesity, tobacco usage and heritable cancer syndromes. The risk of cancer increases greatly in patients over the age of 65. Populations in developed countries are projected to become increasingly aged and show rising obesity incidence, which will drive both cancer prevalence and revenue growth for its treatments.

Hormone therapies for prostate cancers and angiogenesis inhibitors for renal cell carcinoma are currently the most commercially successful urological cancer drugs. However, there has been a shift towards the clinical testing of cancer immunotherapies – such as Opdivo, which was recently approved for renal cell carcinoma.

Browse Detail Report With TOC @
http://www.hexareports.com/report/global-urological-cancer-market
The forecast period will also witness the approval of a greater number of targeted therapies, which by their nature have less toxicity associated with their use, and as a result can be administered to patients with poor performance statuses, therefore increasing the overall survival of this group and the number of treatment cycles they may receive.

Scope
* Global revenues for the urological cancer market are forecast to grow at a Compound Annual Growth Rate (CAGR) of 10.39%, from $17.9 billion in 2015 to $35.9 billion in 2022. Which drugs will achieve blockbuster status and how will the key player companies perform during the forecast period?
* The urologic oncology pipeline is large and diverse, and contains 817 products. How does the composition of the pipeline compare with that of the existing market?
* What mechanisms of action and molecule types are most common for pipeline drugs being trialed in the various key indications?
* How will the market shares and CAGRs of the top 20 companies compare within this therapy area?
* What proportion of the key players’ revenues will be attributable to urological cancers?

Request A Sample copy of This Report @
http://www.hexareports.com/report/global-urological-cancer-market/request-sample

Reasons to buy
1. Understand the current clinical and commercial landscape by considering disease pathogenesis, diagnosis, prognosis, and the treatment options available at each stage of diagnosis
2. Visualize the composition of the urological cancer market across each indication, in terms of dominant molecule types and targets, highlighting the key commercial assets and players
3. Analyze the urological cancer pipeline and stratify by stage of development, molecule type and molecular target, with a granular breakdown across key indications
4. Understand the growth in patient epidemiology and market revenues for the urological cancer market globally and across the key players and product types
5. Stratify the market in terms of the split between generic and premium products, and assess the role of these product types in the treatment of the various urological cancers
6. Identify commercial opportunities in the urological cancer deals landscape by analyzing trends in licensing and co-development deals

Browse More Pharmaceuticals & Healthcare Related Market Research Reports:

• Antibacterial Therapies Drug Development Pipeline Review, 2017 -
http://www.hexareports.com/report/antibacterial-therapies-drug-development-pipeline-review-2017

• Cardiovascular Disorders Drug Development Pipeline Review, 2017 -
http://www.hexareports.com/report/cardiovascular-disorders-drug-development-pipeline-review-2017

• Non-Small Cell Lung Cancer Therapeutics in Asia-Pacific Markets to 2023 -
http://www.hexareports.com/report/non-small-cell-lung-cancer-therapeutics-in-asia-pacific-markets-to-2023

Hematological Cancers Market Overview, Cost Structure Analysis, Growth Opportunities and Forecast to 2022

Hematological malignancies are a class of cancer that affect the blood, lymph nodes and bone marrow. They include numerous forms of leukemia, lymphoma and myeloma. Hematological malignancies constituted 9% of all newly diagnosed malignancies in the US in 2011, with data indicating lymphomas are more prevalent than leukemias or myeloma. Excluding acute lymphocytic leukemia and Hodgkin’s lymphoma, these types of malignancy are generally associated with increasing age. Therefore, considering the aging population globally, this class of malignancy is likely to become more prevalent.

Over the past 15 years, the treatment of hematological malignancies has changed significantly, with the development of targeted therapies. These developments were based on the growing understanding of the signaling pathways involved in disease pathogenesis. Notable examples include the approval of rituximab in 1997, which is used to treat multiple types of hematological malignancies, including Non-Hodgkin’s lymphoma. Overall, there are 1,207 products in active development in the hematological cancer therapy area.

Browse Detail Report With TOC @
http://www.hexareports.com/report/global-hematological-cancers-market-to-2022

The indications included in this disease cluster are classified under oncology, which is the largest therapy area in terms of pipeline products, consisting of 6,936 drugs in development. Hematological cancer has more active pipeline products than the respiratory and cardiovascular therapy areas, which indicates how active this disease cluster is in terms of product development.

Scope
* The hematological cancers market is characterized by commercially successful therapies.
o Which classes of drug dominate the market?
o What additional benefits have newly approved therapies brought to the market?
o How do the leading marketed therapies compare clinically?
* The pipeline contains a range of molecule types and molecular targets, with a strong emphasis on targeted therapies, as opposed to chemotherapeutic agents.
o Which molecular targets appear most frequently in the pipeline?
o What are the commercial prospects for the most promising late-stage pipeline products?
* Hematological cancers clinical trials have an overall attrition rate of 70.3%.
o What are the failure rates at individual Phases of clinical development?
o How do leukemia, lymphoma and myeloma compare in terms of clinical trial failure rate?
* The hematological cancers market is forecast to rise from a value of $30.7 billion in 2015 to $70.1 billion in 2022, at a CAGR of 12.5%.
o How much of a role will disease prevalence and new product approvals play in market growth?
o Will generic competition have a significant impact on the market over the forecast period?

Request A Sample copy of This Report @
http://www.hexareports.com/report/global-hematological-cancers-market-to-2022/request-sample

Reasons to buy
1. Understand the current clinical and commercial landscape through a comprehensive study of disease pathogenesis, diagnosis, prognosis, and the current treatment landscape in hematological cancers.
Assess the current treatment landscape, with product profiles on prominent marketed therapies, including revenue forecasts.
2. Analyze the hematological cancers pipeline and stratify by stage of development, molecule type, and molecular target. The most promising late-stage therapies are profiled and assessed in terms of clinical performance and competitiveness, alongside a single-product forecast.
3. Predict growth in market size, with in-depth market forecasting from 2015 to 2022. The forecasts will provide an understanding of how epidemiology trends, new drug entries, and patent expirations will influence market value.
4. Identify the leading companies in the market, in terms of market share and growth. Company analysis determines how dependent the key companies in the market are on revenue derived from hematological cancer products. In addition, analysis determines the primary factors that will drive market growth for the key companies in the market.
5. Identify commercial opportunities in the hematological cancers deals landscape by analyzing
trends in licensing and co-development deals.

Browse More Pharmaceuticals & Healthcare Related Market Research Reports:

• Melanoma – Heat Map and Analysis -
http://www.hexareports.com/report/melanoma-heat-map-and-analysis

• Cystic Fibrosis – Heat Map and Analysis -
http://www.hexareports.com/report/cystic-fibrosis-heat-map-and-analysis

• Alzheimer’s Disease – Heat Map and Analysis -
http://www.hexareports.com/report/alzheimers-disease-heat-map-and-analysis

Dermatology Market Research Study including Growth Factors, Types and Application by regions from 2017 to 2022

Dermatological conditions are one of the most common types of disorders worldwide, and approximately one-third of the US population suffers from at least one active skin condition.For the past decades, the majority of the dermatology market has remained saturated with established products. However, the clinical and commercial success of biologics in the treatment of psoriasis, as well as advancements in the understanding of the disease pathways of many dermatological conditions, have led to a renewed interest from pharmaceutical companies in the dermatology market, and subsequently the emergence of an innovative pipeline.

This report covers all dermatological disorders, but there is a particular focus on three key diseases: atopic dermatitis, acne vulgaris and psoriasis, as these conditions have the highest prevalence and the largest pipeline. The global dermatology market was valued at $20.0 billion in 2015, and is projected to grow at a considerable Compound Annual Growth Rate (CAGR) of 7.73%, reaching $33.7 billion in 2022. Key drivers of this growth will be the uptake of recently approved premium biologics, as well as promising late-stage products that are expected to be highly valuable.

Browse Detail Report With TOC @
http://www.hexareports.com/report/global-dermatology-market-to-2022

Scope
* The dermatology market landscape is expected to change substantially with the advent of promising novel pipeline products.
* Overall, there are 801 dermatology products in the pipeline, with biologics representing 37% of the pipeline, despite the fact that this molecule type represents only a small fraction of the marketed products landscape.
o Which molecular targets are most prominent within the pipeline?
o How do the key indications differ in terms of molecule type?
o How does the composition of the pipeline compare with that of the existing market?
o What mechanisms of action are most common for pipeline drugs?
* Global revenues for the dermatology market are forecast to grow at a CAGR of 7.73%, from $20 billion in 2015 to $33.7 billion in 2022.
o Which products will contribute to market growth most significantly, and which will achieve blockbuster status?
o Will the current market leaders retain their dominance over the forecast period, and how is their revenue share of the dermatology market set to change?
o What CAGR will these companies register in the forecast period?

Request A Sample copy of This Report @
http://www.hexareports.com/report/global-dermatology-market-to-2022/request-sample

Reasons to buy
1. Understand the current clinical and commercial landscape by considering disease pathogenesis, diagnosis, prognosis and the treatment options available at each stage of diagnosis.
2. Visualize the composition of the dermatology market across each indication, in terms of dominant molecule types and targets, highlighting the key commercial assets and players.
3. Analyze the dermatology pipeline and stratify by stage of development, molecule type and molecular target, with a granular breakdown across key indications.
4. Understand the growth in patient epidemiology and market revenues for the dermatology market globally, and across the key players and product types.
5. Stratify the market in terms of the split between generic and premium products, and assess the role of these product types in the treatment of the various dermatological conditions.
6. Identify commercial opportunities in the dermatology deals landscape by analyzing trends in licensing and co-development deals.

Browse More Pharmaceuticals & Healthcare Related Market Research Reports:

• Dermatology Therapeutics Drug Development Pipeline Review, 2016 -
http://www.hexareports.com/report/dermatology-therapeutics-drug-development-pipeline-review-2016

• Ophthalmology Drug Development Pipeline Review, 2016 -
http://www.hexareports.com/report/ophthalmology-drug-development-pipeline-review-2016

• Diabetes & Obesity Drug Development Pipeline Review, 2016 -
http://www.hexareports.com/report/diabetes-and-obesity-drug-development-pipeline-review-2016

Hematological Cancers Market Research Key Players, Industry Overview, Supply Chain and Analysis 2017 – 2022

Hematological malignancies are a class of cancer that affect the blood, lymph nodes and bone marrow, and include numerous forms of leukemia, lymphoma and myeloma. Hematological malignancies constituted 9% of all newly diagnosed malignancies in the US in 2011, with data indicating that lymphomas are more prevalent than leukemia or myeloma. Excluding acute lymphocytic leukemia and Hodgkin’s lymphoma, these types of malignancy are generally associated with increasing age. Therefore, considering the aging population globally, this class of malignancy is likely to become more prevalent.

The report assesses first-in-class innovation in the hematological cancer pipeline, highlighting key trends in first-in-class product distribution. Analysis reveals that the hematological cancer pipeline is among the most innovative in the industry, with 463 first-in-class products, representing 45.3% of the pipeline with a disclosed molecular target.

Browse Detail Report With TOC @
http://www.hexareports.com/report/frontier-pharma-hematological-cancers

The first-in-class targets in the pipeline are numerous and varied in nature. Cancer immunotherapies are the most common, with a total of 128 across all stages of development, followed by the signal transduction group of targets. The most commercially successful targeted drugs in the market fall into these two categories, including Rituxan (a cancer immunotherapy) and Gleevec (a signal transducer). The other target families have much fewer first-in-class products, reflecting the strong interest in cancer immunotherapies and targets implicated in signal transduction.

Over the past 15 years, the treatment of hematological malignancies has changed significantly, with the development of targeted therapies. These developments have been based on the growing understanding of the signaling pathways involved in disease pathogenesis. A notable example is the approval of Rituxan in 1997, which is used to treat multiple types of hematological malignancies, including Non-Hodgkin’s lymphoma. Analysis indicates that the current pipeline is following this trend of focusing on innovative, targeted therapies.

Request A Sample copy of This Report @
http://www.hexareports.com/report/frontier-pharma-hematological-cancers/request-sample

Scope
* The hematological cancers market is characterized by commercially successful therapies.
o Which classes of drug dominate the market?
o What additional benefits have newly approved therapies brought to the market?
* The pipeline contains a range of molecule types and molecular targets, with a strong emphasis on targeted therapies, as opposed to chemotherapeutic agents.
o Which molecular targets appear most frequently in the pipeline?
o To what degree is the pipeline penetrated by first-in-class innovation?
o Which target families have the most first-in-class products?
* First-in-class products differ substantially in their clinical potential, based on their alignment to disease-causing pathways.
o How well are first-in-class targets aligned to known disease-causing pathways?
o Which targets are specifically found in early-stage development?
o Which are the most promising first-in-class targets in early-stage development?

Reasons to buy
1. Understand the current clinical and commercial landscape. It includes a comprehensive study of disease pathogenesis, diagnosis, prognosis and the treatment options available.
2. Visualize the composition of the hematological cancers market in terms of dominant molecule types and targets, highlighting what the current unmet needs are and how they can be addressed. This knowledge allows a competitive understanding of gaps in the current market.
3. Analyze the hematological cancers pipeline and stratify by stage of development, molecule type and molecular target. There are strong signs in the pipeline that the industry is seeking novel approaches to treating hematological cancers.

Browse More Pharmaceuticals & Healthcare Related Market Research Reports:

• Colorectal Cancer – Heat Map and Analysis -
http://www.hexareports.com/report/colorectal-cancer-heat-map-and-analysis

• Parkinson’s Disease – Heat Map and Analysis -
http://www.hexareports.com/report/parkinsons-disease-heat-map-and-analysis

• Non-Hodgkin Lymphoma – Heat Map and Analysis -
http://www.hexareports.com/report/non-hodgkin-lymphoma-heat-map-and-analysis

Weight Management Market Driver, Constraints, Key Events, Opportunities and Forecast 2014-2025

The global weight management market is expected to reach USD 442.3 billion by 2025, according to a new report by Grand View Research, Inc. Rising number of overweight and obese population coupled with rising popularity of various commercially available solutions is fueling the growth.

Increasing initiatives undertaken by market players in collaboration with the government to raise awareness about the adverse impact on health due to obesity are further anticipated to drive the market demand. The overweight and obese population are more prone to chronic diseases including diabetes, hypertension, and orthopedic diseases. Thus, rising awareness about weight management techniques is driving the market growth.

Browse Detail Report With TOC @
http://www.hexareports.com/report/weight-management-market

Thanks to westernization and urbanization, there is an increasing preference toward processed food as an alternative to home-cooked food. The increase in number of nuclear families coupled with a rise in the working population have fueled the demand for easily accessible & inexpensive fast food and takeaway meals.

According to Statista, in 2015, revenue of fast food industry in the U.S was 203.2 billion. A hectic schedule coupled with increasing stress are resulting in higher intake of outside and takeaway food. This trend is anticipated to trigger the market growth.

Request A Sample copy of This Report @
http://www.hexareports.com/report/weight-management-market/request-sample

Further Key Findings from the Study Suggest:
• The growing prevalence of obesity primarily due to sedentary lifestyle and lesser physical activities is augmenting market growth
• The rising awareness of available solutions for weight loss and management is driving the growth
• In diet, the beverage segment holds the largest share owing to increasing consciousness amongst people about their eating habits and adoption of general & personalized diet plans for better metabolism and losing the extra weight. Whereas, rising popularity of supplements, shake mix, tablets, and capsules are projected to grow over the forecast period
• Fitness equipment such as cardiovascular training, strength building, and other equipment used in maintaining the weight account for the largest share in weight management
• Increasing R&D for developing minimally invasive and noninvasive equipment are anticipated to increase the usage of surgical equipment over the forecast period
• The fitness center services segment held the largest share of market, however with digitalization, online weight loss services are anticipated to grow over the forecast period
• In 2016, North America dominated the global market with the largest revenue share of over 46.0%, due to the rising overweight population and commercial availability of minimally invasive procedures and noninvasive equipment

Table Of Content
Chapter 1 Research Methodology
Chapter 2 Executive Summary
Chapter 3 Weight Management Market Variables, Trends & Scope
Chapter 4 Weight Management Market: Diet Estimates & Trend Analysis
Chapter 5 Weight Management Market: Equipment Estimates & Trend Analysis
Chapter 6 Weight Management Market: Services Estimates & Trend Analysis
Chapter 7 Weight Management Market: Regional Estimates & Trend Analysis, by Diet, Equipment & Services
Chapter 8 Competitive Landscape

Browse More Medical Devices Related Market Research Reports:

• Pressure Relief Devices Market Trend Analysis From 2014-2025 -
http://www.hexareports.com/report/pressure-relief-devices-market

• Hemodialysis and Peritoneal Dialysis Market Trend Analysis From 2014-2025 -
http://www.hexareports.com/report/hemodialysis-and-peritoneal-dialysis-market

• Surgical Instrument Tracking Systems Market Analysis and Segment Forecasts, 2014-2025 -
http://www.hexareports.com/report/surgical-instrument-tracking-systems-market

Surgical Sealants And Adhesives Market Compatitive Landscape and Segmentation Overview by 2014

The global surgical sealants and adhesives market is expected to reach a value of USD 4.5 billion by 2025, according to a new report by Grand View Research, Inc. Proper closure of injured tissues post operation is a major step to restore tissue’s structure and function. Postoperative leakages occur in 3% to 15% of cases and are considered as a serious complication. They are responsible for one third of postoperative deaths in patients. Surgical sealants and adhesives are designed to improve patient outcomes by reducing the prospect of postsurgical complications, such as leakages, thus resulting in improved patient outcomes through prevention of leakage and decrease in length of stay & mortality rates.

The rapid advancements in sealants and adhesives are major impact rendering drivers, and their usage in modern surgery to reduce anastomotic leakage has risen significantly. Surgical adhesive is expected to replace traditional surgical sealing agents such as sutures, wires, and staples. These are time taking, can result in further tissue trauma and hard to use in some surgical locations. Surgical sealants overcome these issues and create immediate and proper sealing, compared to sutures and staples.

Browse Detail Report With TOC @
http://www.hexareports.com/report/surgical-sealants-and-adhesives-market

The factors contributing to the growth of the market are rising demand for surgical services worldwide and increasing concerns to reduce postoperative wound infections. Surgical procedures are increasing worldwide, with WHO estimations projecting surgeries to account for approximately 235 million per year globally.

Increase in rate of surgeries facilitates extensive R&D activities focused on surgical sealants and adhesives, which is expected to support long-term growth of the market.

Request A Sample copy of This Report @
http://www.hexareports.com/report/surgical-sealants-and-adhesives-market/request-sample

Further Key Findings from the Study Suggest:
• North America held the largest market share in 2015 owing to the growing demand of high-quality healthcare in the region
• Asia Pacific is expected to register lucrative growth, due to transformation of healthcare delivery systems into advanced value-based healthcare practices to establish a sustainable health system
• Fibrin sealants accounted for the largest market share in the year 2015
• Cyanoacrylates is expected to register fastest growth in the forecast period owing to its fast drying properties, strong mechanical strength and ease of adhesion
• Surgical sealants and adhesive market participants combine a blend of both large public companies and more specialized small companies. These companies focus on only one segment or product. Example of such companies is Cohera Medical, Inc.
• Some of the leading players in the market are Baxter International, Inc.; CryoLife, Inc.; C.R. Bard, Inc.; Medtronic plc; B. Braun Melsungen AG; Cohera Medical, Inc.; Ethicon, Inc.; Mallinckrodt plc; Cardinal Health; and Integra LifeSciences Holdings Corporation

Table Of Content
Chapter 1. Methodology and Scope
Chapter 2. Executive Summary
Chapter 3. Surgical Sealants and Adhesives Market Variables, Trends & Scope
Chapter 4. Surgical Sealants and Adhesives: Type Estimates & Trend Analysis
Chapter 5. Surgical Sealants and Adhesives: Application Estimates & Trend Analysis
Chapter 6. Surgical Sealants and Adhesives: Regional Estimates & Trend Analysis, by Type and Application
Chapter 7. Competitive Landscape

Browse More Medical Devices Related Market Research Reports:

• Women’s Health Rehabilitation Products Market Analysis and Segment Forecasts, 2014-2025 -
http://www.hexareports.com/report/women-s-health-rehabilitation-products-market

• Disposable Blood Pressure Cuffs Market Analysis and Segment Forecasts, 2014-2025 -
http://www.hexareports.com/report/disposable-blood-pressure-cuffs-market

• Scar Treatment Market Market Analysis and Segment Forecasts, 2014-2025 -
http://www.hexareports.com/report/scar-treatment-market

Orthopedic Navigation Systems Market Research Methodology and Cost Structure analysis 2014-2025

The global orthopedic navigation system market is expected to reach USD 303.7 million by 2025, according to a new study by Grand View Research, Inc. Increasing geriatric population prone to orthopedic diseases is a key contributing factor propelling the demand for orthopedic navigation systems over the forecast period. Osteoarthritis and osteoporosis are most common disorders in the population aged 70 years and above. Growing prevalence of these disorders results in increased economic burden on many countries.

According to the WHO, 9.6% of men and 18% of women are suffering from various forms of arthritis globally. Over 82% of people suffering from osteoarthritis have difficulty in movement and around 25% are not able to perform daily activities. Degenerative joint disorders affect majorly knee, hip, and ankle. Knee and hip replacement procedures are performed in 85% of patients suffering from osteoarthritis. Other factors include physical inactivity, obesity, unhealthy lifestyle, and injuries.

Browse Detail Report With TOC @
http://www.hexareports.com/report/orthopedic-navigation-systems-market

Further Key Findings from the Study Suggest:
• Rising demand for computer-assisted orthopedic surgery due to associated advantages such as low recovery time and shorter hospital stay are anticipated to fuel the industry growth
• Knee navigation systems held the largest market share in 2016 owing to increased adoption by healthcare professionals and ample availability of products
• Asia Pacific regional market is anticipated to witness lucrative growth due to rising incidence of orthopedic disorders and awareness levels amongst consumers regarding benefits of minimally invasive surgery
• High economic development is boosting medical tourism in countries, such as India and China, which is expected to drive the growth by increasing the buying capacity of consumers
• The market is moving toward consolidation, as large pharmaceuticals are focused on strategic acquisitions of smaller companies to gain competitive advantage in coming years
• Companies are striving to gain revenue share via new product development, geographic expansion, and partnership alliances
• For example, Brainlab and De Puy Synthes entered into an extended collaboration for providing effective spine alignment treatment via navigation system

Request A Sample copy of This Report @
http://www.hexareports.com/report/orthopedic-navigation-systems-market/request-sample

Table Of Content
Chapter 1 Research Methodology & Scope
Chapter 2 Executive Summary
Chapter 3 Orthopedic Navigation System Market Variables, Trends & Scope
Chapter 4 Orthopedic Navigation System: Application Estimates & Trend Analysis
Chapter 5 Orthopedic Navigation System: Regional Estimates & Trend Analysis, by Application
Chapter 6 Competitive Landscape

Browse More Medical Devices Related Market Research Reports:

• Airway Management Devices Market Analysis and Segment Forecasts, 2014-2025 -
http://www.hexareports.com/report/airway-management-devices-market

• Sterilization Equipment Market Analysis and Segment Forecasts, 2014-2025 -
http://www.hexareports.com/report/sterilization-equipment-market

• Pancreatic Cancer Treatment Market Analysis and Segment Forecasts, 2014-2025 -
http://www.hexareports.com/report/pancreatic-cancer-treatment-market

Nuclear Medicine Equipment Market Geographical Scope and Manufacture Analysis by 2025

The global nuclear medicine equipment market is expected to reach a value of USD 2.7 billion by 2025, according to a new report by Grand View Research, Inc. Nuclear medicine involves the utilization of radiation to diagnose diseases or treat them. It also involves determining whether specific organs are functioning normally. Over a stretch of the last two decades, rapid technological advancements in nuclear medicine have transformed the medicine practice.

With growing awareness about the importance of early diagnosis of chronic diseases, there has been a noticeable increase in diagnostic nuclear medicine procedures worldwide. This is evident from stats generated from developing countries, which represents about 26% of the world population. These countries conduct diagnostic nuclear medicine tests at a rate of 1.9% per year. In addition, in developed countries such as the U.S., the frequency of nuclear medicine procedures ranges to about 20 million per year.

Browse Detail Report With TOC @
http://www.hexareports.com/report/nuclear-medicine-equipment-market

It is evident that the frequency of use of nuclear medicine and procedures involving radiopharmaceuticals in diagnosis is growing at over 10% per year, indicating a rise in adoption of nuclear medicine equipment worldwide. However, high cost associated with nuclear medicine equipment and insufficient reimbursement support for radiology is expected to hinder the growth of the market. In addition, a growing trend of purchasing refurbished systems for cost saving is expected to affect equipment sales of existing market players.

Further Key Findings from the Study Suggest:
• The North American market is expected to register lucrative growth owing to increasing preference for SPECT and PET scans for diagnosis of chronic diseases
• Growing awareness and government initiatives pertaining to usage of radiopharmaceuticals in the North American region is expected to boost usage rates. For instance, in December 2016, the FDA issued new guidelines to enforce FDA’s proposed policies regarding compounding and repackaging of radiopharmaceuticals for human use in the U.S.
• Oncology accounted for the largest market share in application segment in the year 2015 owing to the increasing incidence and prevalence of cancer worldwide
• Asia Pacific market is expected to witness significant growth owing to Japan, China, and India where use of nuclear medicine is increasing at a fast pace. In addition, the usage of radioimmunotherapy-based targeted cancer treatment to counter incidence of cancer and cardiovascular diseases is aiding in the growth of the market
• Some of the leading vendors operating in the nuclear medicine equipment market are GE Healthcare; Siemens Healthineers; Philips Healthcare; and Toshiba America Medical Systems.
• The key players are focused on expansion & penetration opportunities in developing and emerging economies to achieve sustainable growth in the market

Request A Sample copy of This Report @
http://www.hexareports.com/report/nuclear-medicine-equipment-market/request-sample

Table Of Content
Chapter 1. Methodology and Scope
Chapter 2. Executive Summary
Chapter 3. Nuclear Medicine Equipment Market Variables, Trends & Scope
Chapter 4. Nuclear Medicine Equipment Market: Product Estimates & Trend Analysis
Chapter 5. Nuclear Medicine Equipment Market: Application Estimates & Trend Analysis
Chapter 6. Nuclear Medicine Equipment Market: End Use Estimates & Trend Analysis
Chapter 7. Nuclear Medicine Equipment: Regional Estimates & Trend Analysis, by Product, Application, and End use
Chapter 8. Competitive Landscape

Browse More Medical Devices Related Market Research Reports:

• Orthopedic Navigation Systems Market Analysis and Segment Forecasts, 2014-2025 -
http://www.hexareports.com/report/orthopedic-navigation-systems-market

• Electrosurgical Devices Market Analysis and Segment Forecasts, 2014-2025 -
http://www.hexareports.com/report/electrosurgical-devices-market

• Medical Waste Management Market Analysis and Segment Forecasts, 2014-2025 -
http://www.hexareports.com/report/medical-waste-management-market

Medical Waste Management Market Compatitive Landscape and Segmentation Overview by 2014

The global medical waste management market is expected to reach USD 33.4 billion by 2025, according to a new report by Grand View Research, Inc. The development of innovative manufacturing techniques in pharmaceuticals, medical devices is growing with rapid pace. The rise in hospitals, multispecialty clinics and diagnostic centers that require large number of inventories for day to day functioning is also leading to generation of more waste. Thus, overall growth in healthcare industry coupled with rising patient population requiring prolong medical and surgical aid is fueling the market growth.

Rapid growth in initiatives by government to support and raise funds in effective waste management is anticipated to drive the market growth. These programs are conducted for creating awareness regarding the importance of systems for proper waste disposal. Additionally, taking steps to set standards and guidelines for the same is anticipated to propel the market growth.

Browse Detail Report With TOC @
http://www.hexareports.com/report/medical-waste-management-market

The medical waste management involves high capital investment for managing hazardous by-products and disposal of infectious material. This disposal and recycling processes are associated with release of hazardous gases and compounds which may disturb the ecosystem and are likely to affect the industry growth.

Further Key Findings from the Study Suggest:
• The growing prevalence of infectious and chronic diseases coupled with overall growth of healthcare industry is augmenting the market growth
• Most of the waste disposal treatments are performed offsite, however, to save cost and holding time, onsite treatment sites are expected to grow over the forecast period
• The incineration segment accounted for the largest revenue share in 2016 however, other sophisticated non-incineration processes that are ecofriendly are projected to replace traditional incinerators
• In 2016, North America dominated the global space with the largest revenue share of over 32.0% owing to growing healthcare industry and development of innovative techniques for disposal of material
• Asia Pacific is expected to emerge as the fastest growing region during the forecast period, mainly due to growing social awareness regarding effective disposal and recycling.
• Major players competing in the industry include but are not limited to Remondis Medison GmbH; Republic Services, Inc.; Sharp Compliance, Inc.; Stericycle, Inc.; Suez Environment, Inc.; Veolia Environment S.A.; Waste Management, Inc.

Request A Sample copy of This Report @
http://www.hexareports.com/report/medical-waste-management-market/request-sample

Table Of Content
Chapter 1 Research Methodology
Chapter 2 Executive Summary
Chapter 3 Medical Waste Management Market Variables, Trends & Scope
Chapter 4 Medical Waste Management Market: Services Estimates & Trend Analysis
Chapter 5 Medical Waste Management Market: Treatment Estimates & Trend Analysis
Chapter 6 Medical Waste Management Market: Regional Estimates & Trend Analysis, by Drug Class and Application
Chapter 7 Competitive Landscape

Browse More Medical Devices Related Market Research Reports:

• Medical Device Outsourcing Market Analysis and Segment Forecasts, 2014-2025 -
http://www.hexareports.com/report/medical-device-outsourcing-market

• Clinical Chemistry Analyzers Market Analysis and Segment Forecasts, 2014-2025 -
http://www.hexareports.com/report/clinical-chemistry-analyzers-market

• Dermatology Devices Market Analysis and Segment Forecasts, 2014-2025 -
http://www.hexareports.com/report/dermatology-devices-market

Dermatology Devices Market Research Methodology and Cost Structure analysis 2014-2025

The global dermatology devices market is expected to reach a value of USD 25.7 billion by 2025, according to a new report by Grand View Research, Inc. Dermatology devices are expected to grow at a faster rate due to rising concern amongst people regarding esthetics. This has led to rising awareness about various types of esthetic procedures used for treating hair- and skin-related disorders. Primarily, women suffer from these disorders. Hence, they are considered as the highest revenue generators for the market.

Incidence of skin disorders is continuously rising amongst people owing to their irregular lifestyle and food habits. Skin disorders such as psoriasis, acne, eczema, and skin lesions are some of the common skin ailments amongst people. Melanoma is a life-threatening skin cancer, which often results due to these skin disorders. Dermatology diagnostic devices help in the early diagnosis of such deadly cancerous diseases.

Browse Detail Report With TOC @
http://www.hexareports.com/report/dermatology-devices-market

Obesity has become one of the major issues for both the male and female population. Hence, fat removal procedures are being highly adopted. Liposuction is considered as an effective treatment for obese people. Moreover, the geriatric population is also highly concerned about their esthetic appearance.

In order to enhance their esthetic appeal, they go for skin tightening and wrinkle removal procedures. In addition, technological advancements in laser treatments are continuously growing for dermatology devices market, which is making it a lucrative field for people concerned with esthetics.

Request A Sample copy of This Report @
http://www.hexareports.com/report/dermatology-devices-market/request-sample

Further Key Findings from the Study Suggest:
• Imaging devices dominated the market in 2015 due to high incidence of skin cancer and technological advancements in related products
• Light therapy devices held the largest market share in 2015 due to its wide usability by dermatologists for skin lesion treatment
• Skin cancer diagnosis was the highest revenue generator segment in 2015 owing to the high prevalence of skin cancer, particularly, melanoma
• Vascular and pigmented lesion removal dominated the market in 2015 due to the high susceptibility of vascular lesion leading to skin tumor
• Acne, psoriasis, and tattoo removal is expected to gain lucrative growth over the forecast period due to growing number of people experiencing acne related problems
• North America dominated in 2015 owing to the high penetration of light therapy and laser-based instruments in the field of dermatology devices and skin rejuvenation
• Some of the key companies include Cynosure, Inc., LUMENIS, Valeant Pharmaceuticals International Inc., Alma Lasers, Ltd., Cutera, Inc., Syneron Medical Ltd., and Avita Medical Ltd.

Table Of Content
Chapter 1 Research Methodology
Chapter 2 Executive Summary
Chapter 3 Dermatology Devices Market Variables, Trends & Scope
Chapter 4 Dermatology Devices Market: Product Estimates & Trend Analysis
Chapter 5 Dermatology Devices Market: End-Use Estimates & Trend Analysis
Chapter 6 Dermatology Devices Market: Regional Estimates & Trend Analysis, by Product, End Use
Chapter 7 Competitive Landscape

Browse More Medical Devices Related Market Research Reports:

• Nuclear Medicine Equipment Market Analysis and Segment Forecasts, 2014-2025 -
http://www.hexareports.com/report/nuclear-medicine-equipment-market

• Surgical Sealants And Adhesives Market Analysis and Segment Forecasts, 2014-2025 -
http://www.hexareports.com/report/surgical-sealants-and-adhesives-market

• Weight Management Market Analysis and Segment Forecasts, 2014-2025 -
http://www.hexareports.com/report/weight-management-market

Antipsychotic Drugs Market Geographical Scope and Manufacture Analysis by 2025

The global antipsychotic drugs market is expected to reach USD 14.4 billion by 2025, according to a new report by Grand View Research, Inc. The continuous development of better next-generation products to overcome adverse effects and unwanted reactions of existing products is creating demand for newer products. This factor is anticipated to propel the market.

Rapid growth of antipsychotics can be attributed to the rising prevalence of psychosis and other mental disorders. Governments are focused on creating awareness regarding mental health and psychological illnesses, which is further anticipated to drive the demand for antipsychotics. Government bodies in collaboration with major players conduct social programs to break the stigma related to psychotic disorders that exists in the society.

Browse Detail Report With TOC @
http://www.hexareports.com/report/antipsychotic-drugs-market

Adverse effects of antipsychotics, such as insomnia, dry mouth, drowsiness, and blurred vision, are expected to affect the growth by decreasing the level of acceptance in patients. In addition, the possibility of dependency, habit formation, or addiction is affecting the adoption of these drugs.
Established brands such as, Zyprexa lost patent protection in October 2011, followed by Seroquel and Risperdal in 2012, which hampers the market growth for these drugs. Also, the entry of generic versions of these products slowed the growth of the already existing brands.

Request A Sample copy of This Report @
http://www.hexareports.com/report/antipsychotic-drugs-market/request-sample

Further Key Findings from the Study Suggest:
• The growing prevalence of mental disorders, increased investments on R&D, and rising awareness regarding these conditions are augmenting the growth of the market.
• The first-generation of antipsychotics have serious adverse effects and are very rarely used, hence they hold negligible share in the market.
• The second-generation segment of drugs accounted for the largest share in 2015 and are anticipated to further expand during the forecast period despite the adverse effects
• As of January 2016, the third-generation segment has only one approved product, Abilify. It has negligible adverse effects and is expected to be the fastest growing segment over the forecast period
• In 2015, North America dominated the global space with the largest revenue share owing to rising prevalence of mental illnesses
• Asia Pacific is expected to emerge as the fastest growing region during the forecast period, mainly due to growing social awareness regarding mental disorders and improving access to treatment
• Some of the major players in this market are Johnson & Johnson; Pfizer, Inc.; Eli Lilly & Co.; and Bristol-Myers Squibb

Table Of Content
Chapter 1 Research Methodology
Chapter 2 Executive Summary
Chapter 3 Antipsychotic Drugs Market Variables, Trends & Scope
Chapter 4 Antipsychotic Drugs Market: Drug Class Estimates & Trend Analysis
Chapter 5 Antipsychotic Drugs Market: Application Estimates & Trend Analysis
Chapter 6 Antipsychotic Drugs Market: Regional Estimates & Trend Analysis, by Drug Class and Application
Chapter 7 Competitive Landscape

Browse More Pharmaceutical Related Market Research Reports:

• Antiviral Drugs Market Analysis and Segment Forecasts, 2014-2025 -
http://www.hexareports.com/report/antiviral-drugs-market

• Gastroesophageal Reflux Disease (GERD) Therapeutics Market Analysis and Segment Forecasts, 2014-2025 -
http://www.hexareports.com/report/gastroesophageal-reflux-disease-gerd-therapeutics-market

• Animal Health Market Analysis and Segment Forecasts, 2014-2025 -
http://www.hexareports.com/report/animal-health-market

Ventilator Associated Pneumonia Market Growth Forecast, Demand and Development Research Report to 2021

Ventilator-associated pneumonia (VAP) is a type of pneumonia that happens after endotracheal incubation, featured by the presence of a new or progressive virus. VAP is predicted to occur in quarter of all mechanically ventilated patients along with higher risk of being early in course of hospitalization. Risk for VAP is greatest during the first initial days of mechanical ventilation between the intubation and development of VAP. In the recent years, the accumulated risk of death has decreased and is more recently estimated at a significant percentage.

VAP is a serious complication of mechanical ventilation which increases the patient’s stay in ICU and overall length of hospital incurs additional costs and is a most common of all nosocomial infections contributing to death. The risk factor is the endotracheal tube as mechanical ventilator support cannot be performed without the endotracheal tube. The endotracheal tube provides a direct passageway into the lungs, that bypasses natural protection mechanisms. Hence, the endotracheal tube augments the risk for VAP by; preventing cough, preventing upper airway filtering, preventing upper airway humidification, having a cuff that provides a place for secretions to pool in the hypoglottic area.

Browse Detail Report With TOC @ http://www.hexareports.com/report/global-ventilator-associated-pneumonia-vap-market-professional-survey-report-2016

The key driving factors responsible for the growth of ventilator associated pneumonia market includes growth in geriatric population and rising number of pneumonic patients especially in the cold countries. Additionally, government funding to eradicate lack of medical infrastructure for sparsely populated areas is also contributing to the growth of ventilator associated pneumonia market. On the basis of diagnosis types, the global ventilator associated pneumonia market is segmented into clinical, radiological and microbiological. Clinical segment dominated the global market owing to growth in number of pneumonic patients.

On the basis of end users, the global ventilator associated pneumonia market is segmented into hospitals, research centers and clinics. Hospital segment dominated the global market owing rising incidence of pneumonia and need for immediate medical assistance.

On the basis of geographic segmentation, the global associated ventilator pneumonia market spans North America, Europe, China, Southeast Asia, Japan and India. North America dominates the global market due to growth in increasing rates of pneumonias. Europe is the second large market for ventilator-associated pneumonia (VAP) and is witnessed a higher CAGR during the assessment period. APAC regions also witnessed a higher CAGR growth during the assessment period. The key players in the global ventilator associated pneumonia market include Philips Respironics, Tyco, Hoffrichter, ResMed, Teleflex, Weinmann, Fisher & Paykel, and SYSMED.

Request A Sample copy of This Report @ http://www.hexareports.com/report/global-ventilator-associated-pneumonia-vap-market-professional-survey-report-2016/request-sample

Table Of Content
* Global Ventilator-associated pneumonia Market Competition by Manufacturers
* Global Ventilator-associated pneumonia Analysis by Region
* Global Ventilator-associated pneumonia Analysis by Type
* Global Ventilator-associated pneumonia Market Analysis by Application
* Global Ventilator-associated pneumonia Manufacturers Analysis
* Ventilator-associated pneumonia Technology and Development Trend

Browse More Medical Devices Related Market Research Reports:

• Global Gastrostomy Feeding Tubes Sales Market Report 2017 -
http://www.hexareports.com/report/global-gastrostomy-feeding-tubes-sales-market-report-2017

• Global General Medical Device Sales Market Report 2017 -
http://www.hexareports.com/report/global-general-medical-device-sales-market-report-2017

• Europe Robotic Assisted Surgery System Market Report 2017 -
http://www.hexareports.com/report/europe-robotic-assisted-surgery-system-market-report-2017